Search results
Results from the WOW.Com Content Network
It is also used in the treatment of high blood pressure, and low blood potassium that does not improve with supplementation, early puberty in boys, acne and excessive hair growth in women. [4] [22] [23] It can also be used to block the effects of testosterone in transgender women and nonbinary people undergoing feminizing hormone replacement ...
Over time, insomnia can also contribute to chronic health issues like heart disease, high blood pressure, obesity, chronic pain syndrome and diabetes. What are the causes or risk factors for insomnia?
A prescription medication, spironolactone blocks androgen production that decreases the amount of DHT, the hormone that causes hair follicles to shrink and hair shafts to become thinner and finer.
The AR antagonism of spironolactone mostly underlies its antiandrogenic activity and is the major mechanism responsible for its therapeutic benefits in the treatment of androgen-dependent conditions like acne, hirsutism, and pattern hair loss and its usefulness in hormone therapy for transgender women.
Occasionally, this insomnia may be worse than the insomnia the drug was intended to treat. [1] Common medicines known to cause this problem are eszopiclone , zolpidem , and anxiolytics such as benzodiazepines and which are prescribed to people having difficulties falling or staying asleep.
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively clearing up 'waste', though it remains unclear whether this could affect ...
Someday, the discovery might even lead to major advances in treatment. But those advances have not yet been made. All of the sleep medicine experts I interviewed emphasized that therapy and behavioral changes remain the best treatments for insomnia. Like most other sleep drugs, Belsomra provides only mild relief.
The Randomized Aldactone Evaluation Study (RALES) trial is a landmark clinical study that assessed the impact of spironolactone, an aldosterone antagonist, on morbidity and mortality in patients with severe heart failure due to systolic dysfunction. [1] The findings from this trial significantly influenced the treatment guidelines for heart ...